Nutra Pharma Corp.
Bringing Healthcare Solutions to the World
 
Newsroom
Recent News
Archives
E-Alerts
Press Kit
Drug Development
R&D Pipeline
Nutra Pharma is developing an innovative pipeline of biopharmaceutical products
E-Alerts
Signup to receive news and announcements from Nutra Pharma:
First Name:
Last Name:
Email:
Infinite Menus, Copyright 2006, OpenCube Inc. All Rights Reserved.

Newsroom

Health on the Net Foundation Accredits Nutra Pharma Website
April 19, 2006

Nutra Pharma Corp., a biotechnology company that is developing drugs for HIV and Multiple Sclerosis (MS), has today announced that the Health On the Net (HON) Foundation has accredited the Nutra Pharma website as being compliant with the HONcode.

The Health On the Net Foundation is a Geneva-based non-profit organization established to promote and guide the deployment of useful and reliable online medical and health information on the web. Established in 1995, the Health On the Net Foundation was founded by a group of leading telemedicine professionals.

“We are honored to receive this prestigious accreditation from the HON Foundation in Switzerland,” explained Rik J Deitsch, CEO of Nutra Pharma Corporation. “By following the HONcode set of principals, visitors to our website know that they are receiving credible and reliable information. We are now working with the World Health Organization and the Stop TB Partnership. Understanding that there are an increasing number of organizations relying on the data from the HON Foundation, our accreditation will ensure our future acceptance within these organizations,” he concluded.

Previous recipients of the HONcode accreditation include: WebMD, Mayo Clinic, Johns Hopkins Department of Medical Emergency, and Mount Sinai Hospital.

SEC Disclaimer

This press release contains forward-looking statements. The words or phrases "would be," "will allow," "intends to," "will likely result," "are expected to," "will continue," "is anticipated," "estimate," "project," or similar expressions are intended to identify "forward-looking statements." Actual results could differ materially from those projected in Nutra Pharma's ("the Company") business plan. The Company's business is subject to various risks, which are discussed in the Company's filings with the Securities and Exchange Commission ("SEC"). The Health on the Net Foundation Accreditation should not be construed as an indication in any way whatsoever of the value of the Company or its common stock. The Company's filings may be accessed at the SEC's Edgar system at www.sec.gov. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company cautions readers not to place reliance on such statements. Unless otherwise required by applicable law, we do not undertake, and we specifically disclaim any obligation, to update any forward-looking statements to reflect occurrences, developments, unanticipated events or circumstances after the date of such statement.


 
Quick Nav
Nyloxin // Chronic Pain Relief
Read about Jeff Gottfurcht, the first rheumatoid arthritis sufferer to conquer Everest, in Musculoskeletal Health a special section of the Washington Post.
 

 

 
Recent News
 
August 03, 2017
New Edition of Textbook on Treating Canine Arthritis Includes Nutra Pharma Pain Remedy


June 21, 2017
Nutra Pharma Announcing Launch of Luxury Feet


June 07, 2017
Nutra Pharma Featured on Univision's Spanish-Language News Show: Primer Impacto


 
 
Announcements
Click here to view a Letter to Shareholders from the Company's CEO, Rik J Deitsch.
 
 
Facebook   Twitter
 
NPC
Privacy Policy Code of Ethics